Cheap drug duo could help millions lose weight

NCT ID NCT07588750

NEW Not yet recruiting Disease control Sponsor: Falquetomed Source: ClinicalTrials.gov ↗

First seen May 16, 2026 · Last updated May 16, 2026

Summary

This study reviews medical records of 500 adults with obesity or overweight to see if a combination of two affordable drugs, sibutramine and topiramate, helps with weight loss in real-world clinics. Participants must have taken the drugs for at least 3 months. The goal is to measure weight and BMI changes, along with safety and side effects.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBESITY/OVERWEIGHT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Falqueto Med - N1 Centro Clínico

    Venda Nova do Imigrante, Espírito Santo, 29375000, Brazil

Conditions

Explore the condition pages connected to this study.